These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 708572
1. Oncogenic transformation in vitro by the hypoxic cell sensitizer misonidazole. Miller RC, Hall EJ. Br J Cancer; 1978 Sep; 38(3):411-7. PubMed ID: 708572 [Abstract] [Full Text] [Related]
2. In vitro assessment of the oncogenic potential of nitroimidazole radiosensitizers. Hei TK, Geard CR, Osmak RS, Hall EJ. Int J Radiat Oncol Biol Phys; 1985 Sep; 11(9):1653-8. PubMed ID: 3839777 [Abstract] [Full Text] [Related]
3. Oncogenic transforming potential of nitroimidazole radiosensitizers. Hall EJ, Hei TK. Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1231-4. PubMed ID: 2523882 [Abstract] [Full Text] [Related]
4. Oncogenic transformations in vitro produced by misonidazole. Miller RC, Hall EJ. Cancer Clin Trials; 1980 May; 3(1):85-90. PubMed ID: 7389040 [Abstract] [Full Text] [Related]
6. Comparison of the incidence of oncogenic transformation produced by X rays, misonidazole, and chemotherapy agents. Hall EJ, Miller RC, Osmak R, Zimmerman M. Radiology; 1982 Nov; 145(2):521-3. PubMed ID: 6182579 [Abstract] [Full Text] [Related]
7. Oncogenic transformation systems involving mammalian cells in vitro to determine the relative risks of different treatment modalities. Hall EJ. Strahlentherapie; 1984 Dec; 160(12):725-31. PubMed ID: 6515665 [Abstract] [Full Text] [Related]
8. Modification of the action of misonidazole. III. The effect of diamide on toxicity and radiosensitization. Skov KA, Palcic B, Skarsgard LD. Int J Radiat Biol Relat Stud Phys Chem Med; 1981 Oct; 40(4):335-45. PubMed ID: 6975248 [Abstract] [Full Text] [Related]
10. Studies on the toxicity and radiosensitizing ability of misonidazole under conditions of prolonged incubation. Wong TW, Whitmore GF, Gulyas S. Radiat Res; 1978 Sep; 75(3):541-55. PubMed ID: 724984 [No Abstract] [Full Text] [Related]
11. Interaction of radiosensitizers and WR-2721. I. Modification of skin radioprotection. Rojas A, Stewart FA, Denekamp J. Br J Cancer; 1982 May; 45(5):684-93. PubMed ID: 6282299 [Abstract] [Full Text] [Related]
12. Combined application of misonidazole and piotron pions on mouse embryos. Michel C, Cordt-Riehle I, Fritz-Niggli H, Schäppi K. Radiat Environ Biophys; 1983 May; 21(3):155-62. PubMed ID: 6844547 [Abstract] [Full Text] [Related]
14. Studies with bifunctional bioreductive drugs. I. In vitro oncogenic transforming potential. Hei TK, He ZY, Piao CQ, Hall EJ. Radiat Res; 1990 Oct; 124(1 Suppl):S44-9. PubMed ID: 2236509 [Abstract] [Full Text] [Related]
15. Oncogenic transforming potential of etanidazole. Hall EJ, Hei TK. Int J Radiat Oncol Biol Phys; 1992 Oct; 22(4):743-5. PubMed ID: 1531978 [Abstract] [Full Text] [Related]
16. Oncogenic transformation of mammalian cells in vitro with split doses of x-rays. Miller RC, Hall EJ, Rossi HH. Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5755-8. PubMed ID: 293680 [Abstract] [Full Text] [Related]
19. Enhancement of artificial lung metastases by misonidazole. Rockwell S, Nierenburg M, Irvin CG. Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1395-8. PubMed ID: 6469763 [Abstract] [Full Text] [Related]
20. Misonidazole enhancement of acute and late radiation injury to the rat spinal cord. Yuhas JM. Br J Cancer; 1979 Jul; 40(1):161-3. PubMed ID: 454561 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]